Talon Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$387.2M

509 transactions

Summary

Talon Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $4.8MSales: $25.8M40 insiders

Date	Insider	Type	Value
2013-07-17	CARLSON CRAIG W(Chief Financial Officer)	D	$0
2013-07-17	CARLSON CRAIG W(Chief Financial Officer)	D	$0
2013-07-17	CARLSON CRAIG W(Chief Financial Officer)	D	$0
2013-07-17	CARLSON CRAIG W(Chief Financial Officer)	D	$0
2013-07-17	CARLSON CRAIG W(Chief Financial Officer)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	$0
2013-07-17	DEITCHER STEVEN R(President & CEO)	D	—
2013-07-17	DeZao Thomas(VP, Comm. Oper. & Planning)	D	$0
2013-07-17	DeZao Thomas(VP, Comm. Oper. & Planning)	D	$0
2013-07-17	Furst Howard P.	D	$0
2013-07-17	Furst Howard P.	D	$0
2013-07-17	Furst Howard P.	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Talon Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope